£ (Millions) | £ (Millions) | £ (Millions) | £ (Millions) | £ (Millions) | |
31-Mar-25 | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | 31-Mar-21 | |
Continuing Operations | |||||
Revenue | 970.90 | 949.60 | 639.00 | 982.10 | 829.20 |
EBITDA | 572.50 | 577.10 | 335.20 | 637.10 | 581.60 |
Depreciation & Amortisation | (17.80) | (18.00) | (39.50) | (18.10) | (15.50) |
Operating Profit/(Loss) | 554.70 | 559.10 | 295.70 | 619.00 | 566.10 |
Interest Payable | (43.70) | (49.50) | (64.60) | (53.10) | (56.80) |
Interest Receivable/Investment Income | 19.50 | 21.60 | 15.50 | n/a | n/a |
Group Profit after Interest | 530.50 | 531.20 | 246.60 | 565.90 | 509.30 |
Share of Assoc Cos/JV Profits | n/a | (0.40) | 4.40 | (0.50) | 0.20 |
Profit Before Tax | 530.50 | 530.80 | 251.00 | 565.40 | 509.50 |
Tax | (79.30) | (62.40) | (29.40) | (31.10) | (48.50) |
Profit After Tax | 451.20 | 468.40 | 221.60 | 534.30 | 461.00 |
Discontinued Operations | |||||
Profit After Tax | n/a | 6.00 | 56.80 | (9.20) | n/a |
PROFIT FOR PERIOD | 451.20 | 474.40 | 278.40 | 525.10 | 461.00 |
Attributable to: | |||||
Equity Holders of Parent Company | 451.20 | 473.40 | 278.40 | 526.80 | 457.10 |
Minority Interests | n/a | (1.00) | n/a | 1.70 | (3.90) |
Equity Dividends | cn/a | cn/a | cn/a | cn/a | cn/a |
Retained Profit/(Loss) for the Financial Year | c451.20 | c473.40 | c278.40 | c526.80 | c457.10 |
Per Share Record - Normalised | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | 31-Mar-21 |
Continuing EPS | |||||
Earnings per Share - Basic | 157.09p | 163.36p | 77.59p | 186.92p | 160.30p |
Earnings per Share - Diluted | 153.78p | 160.06p | 76.59p | 184.22p | 157.51p |
Earnings per Share - Adjusted | 157.10p | 163.40p | 77.60p | 183.70p | 160.30p |
Continuing and Discontinued EPS | |||||
Earnings per Share - Basic | 157.09p | 165.45p | 97.47p | 183.71p | 1.62p |
Earnings per Share - Diluted | 153.78p | 162.12p | 96.23p | 181.06p | 1.59p |
Earnings per Share - Adjusted | 157.10p | 165.50p | 98.20p | 183.70p | 160.30p |
Dividend per Share | 83.00p | 79.00p | 77.50p | 76.00p | 56.00p |
Key Financals | 31-Mar-25 | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | 31-Mar-21 |
Shares in Issue (millions) | |||||
Shares in Issue - Year End | 294.37 | 294.36 | 294.33 | 294.29 | 294.28 |
Weighted Average | 287.22 | 286.12 | 285.61 | 286.76 | 285.15 |
Diluted | 293.40 | 292.01 | 289.31 | 290.95 | 290.20 |
Performance Ratios | |||||
Continuing Operations | |||||
Operating Margin | 57.13% | 58.88% | 46.28% | 63.03% | 68.27% |
Return on Capital Employed | 22.35% | 24.22% | 3.67% | 7.71% | 0.08% |
Continuing Operations & Discontinued Operations | |||||
Return on Equity | 18.06% | 20.37% | 13.55% | 26.51% | 0.29% |
Financial Status | |||||
Continuing Operations | |||||
Interest Cover - Continuing | 13.14 | 11.72 | 4.89 | 11.65 | 9.97 |
Revenue per Share | 338.03p | 331.88p | 223.73p | 342.48p | 2.94p |
Pre-Tax Profit Per Share - Continuing | 184.70p | 185.51p | 87.88p | 197.17p | 1.80p |
Market Data | |||||
Continuing Operations | |||||
Earnings Per Share Growth - Basic | -4% | 110% | -58% | 17% | 319% |
Earnings Per Share Growth - Diluted | -4% | 109% | -58% | 17% | 320% |
PE Ratio - Company Adjusted | 12.4 | 12.6 | 15.7 | 9.6 | 11.5 |
PEG - Company Adjusted | n/a | 0.1 | n/a | 0.6 | 0.0 |
Dividend Cover | 1.89 | 2.07 | 1.00 | 2.46 | 2.86 |
Continuing Operations & Discontinued Operations | |||||
Earnings per Share - Company Adjusted | -5% | 70% | -47% | 11,254% | -96% |
Earnings per Share - Diluted | -5% | 68% | -47% | 11,288% | -96% |
PE Ratio - Company Adjusted | 12.4 | 12.4 | 12.5 | 9.7 | 1,138.4 |
PEG - Company Adjusted | n/a | 0.2 | n/a | 0.0 | n/a |
Dividend Cover | 1.89 | 2.09 | 1.26 | 2.42 | 0.03 |
Market Capitalisation £ (Millions) | 5,751.99 | 6,046.08 | 3,582.02 | 5,254.47 | 5,420.57 |
Dividend per Share | 83.00p | 79.00p | 77.50p | 76.00p | 56.00p |
Dividend Yield | 4.2% | 3.8% | 6.4% | 4.3% | 3.0% |
Dividend per Share Growth | 5.06% | 1.94% | 1.97% | 35.71% | 10.24% |
* GAAP
a. Includes discontinued activities
b. Includes preference dividends
c. Not disclosed under IFRS
You are here: research